Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
35521 | 96 | 26.7 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
547 | 3 | ACETAMINOPHEN//CARBON MONOXIDE POISONING//POISONING | 18371 |
3624 | 2 | DEXTROMETHORPHAN//LEVODROPROPIZINE//COUGH AND COLD MEDICATIONS | 1226 |
35521 | 1 | LEVODROPROPIZINE//ANGIOENCEPHALOPATHY//DROPROPIZINE | 96 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LEVODROPROPIZINE | authKW | 2968733 | 15% | 67% | 14 |
2 | ANGIOENCEPHALOPATHY | authKW | 954239 | 3% | 100% | 3 |
3 | DROPROPIZINE | authKW | 565470 | 4% | 44% | 4 |
4 | AND MACROPHAGES | authKW | 318080 | 1% | 100% | 1 |
5 | ANGIODYSGENETIC NECROTIZING ENCEPHALOPATHY | authKW | 318080 | 1% | 100% | 1 |
6 | CAS 99291 25 5 | authKW | 318080 | 1% | 100% | 1 |
7 | CENTRENCEPHALIC LESION | authKW | 318080 | 1% | 100% | 1 |
8 | CHRONIC RESPIRATORY IMPAIRMENT | authKW | 318080 | 1% | 100% | 1 |
9 | CLIN HOSP AFFILIATED 2 | address | 318080 | 1% | 100% | 1 |
10 | COLONY FORMING UNITS GRANULOCYTES | authKW | 318080 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 504 | 43% | 0% | 41 |
2 | Chemistry, Medicinal | 287 | 17% | 0% | 16 |
3 | Clinical Neurology | 76 | 14% | 0% | 13 |
4 | Medicine, General & Internal | 36 | 10% | 0% | 10 |
5 | Respiratory System | 30 | 5% | 0% | 5 |
6 | Electrochemistry | 17 | 4% | 0% | 4 |
7 | Chemistry, Analytical | 12 | 6% | 0% | 6 |
8 | Medical Laboratory Technology | 12 | 2% | 0% | 2 |
9 | Medicine, Research & Experimental | 11 | 5% | 0% | 5 |
10 | Nutrition & Dietetics | 9 | 3% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN HOSP AFFILIATED 2 | 318080 | 1% | 100% | 1 |
2 | STANDORT WESTEND KLINIKUM SPANDAUER DAMM 130 | 318080 | 1% | 100% | 1 |
3 | UNITE PHARMACOEPIDEMIOL PROJET EACH | 318080 | 1% | 100% | 1 |
4 | GLUCAN CORP | 254461 | 2% | 40% | 2 |
5 | DAY HOSP ONCOL MED | 159039 | 1% | 50% | 1 |
6 | RIS | 94238 | 4% | 7% | 4 |
7 | P MED PULM REHABIL SECT | 53012 | 1% | 17% | 1 |
8 | IND COOPERAT FDN | 47556 | 4% | 4% | 4 |
9 | HERBAL BIOTECHNOL | 45436 | 2% | 7% | 2 |
10 | QIGONG | 39758 | 1% | 13% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GAZETTE MEDICALE | 5779 | 2% | 1% | 2 |
2 | SEMAINE DES HOPITAUX | 4595 | 7% | 0% | 7 |
3 | THERAPIE | 4505 | 6% | 0% | 6 |
4 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 3544 | 7% | 0% | 7 |
5 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 2758 | 4% | 0% | 4 |
6 | PULMONARY PHARMACOLOGY & THERAPEUTICS | 1936 | 3% | 0% | 3 |
7 | EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION | 1302 | 1% | 0% | 1 |
8 | PHARMACEUTICAL CHEMISTRY JOURNAL | 1143 | 2% | 0% | 2 |
9 | CURRENT PHARMACEUTICAL ANALYSIS | 719 | 1% | 0% | 1 |
10 | JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY | 652 | 3% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LEVODROPROPIZINE | 2968733 | 15% | 67% | 14 | Search LEVODROPROPIZINE | Search LEVODROPROPIZINE |
2 | ANGIOENCEPHALOPATHY | 954239 | 3% | 100% | 3 | Search ANGIOENCEPHALOPATHY | Search ANGIOENCEPHALOPATHY |
3 | DROPROPIZINE | 565470 | 4% | 44% | 4 | Search DROPROPIZINE | Search DROPROPIZINE |
4 | AND MACROPHAGES | 318080 | 1% | 100% | 1 | Search AND+MACROPHAGES | Search AND+MACROPHAGES |
5 | ANGIODYSGENETIC NECROTIZING ENCEPHALOPATHY | 318080 | 1% | 100% | 1 | Search ANGIODYSGENETIC+NECROTIZING+ENCEPHALOPATHY | Search ANGIODYSGENETIC+NECROTIZING+ENCEPHALOPATHY |
6 | CAS 99291 25 5 | 318080 | 1% | 100% | 1 | Search CAS+99291+25+5 | Search CAS+99291+25+5 |
7 | CENTRENCEPHALIC LESION | 318080 | 1% | 100% | 1 | Search CENTRENCEPHALIC+LESION | Search CENTRENCEPHALIC+LESION |
8 | CHRONIC RESPIRATORY IMPAIRMENT | 318080 | 1% | 100% | 1 | Search CHRONIC+RESPIRATORY+IMPAIRMENT | Search CHRONIC+RESPIRATORY+IMPAIRMENT |
9 | COLONY FORMING UNITS GRANULOCYTES | 318080 | 1% | 100% | 1 | Search COLONY+FORMING+UNITS+GRANULOCYTES | Search COLONY+FORMING+UNITS+GRANULOCYTES |
10 | DAILY LIFE MEMORY TEST | 318080 | 1% | 100% | 1 | Search DAILY+LIFE+MEMORY+TEST | Search DAILY+LIFE+MEMORY+TEST |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZAYED, SIM , ARIDA, HAM , (2015) VOLTAMMETRIC DETERMINATION OF THE COUGH SUPPRESSANT DRUG DROPROPIZINE IN ITS PHARMACEUTICAL FORMULATIONS AND HUMAN URINE.INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE. VOL. 10. ISSUE 4. P. 3250 -3259 | 6 | 100% | 0 |
2 | JANG, JW , SEO, JH , JO, MH , LEE, YJ , CHO, YW , YIM, SV , LEE, KT , (2013) RELATIVE BIOAVAILABILITY OF LEVODROPROPIZINE 60 MG CAPSULE AND SYRUP FORMULATIONS IN HEALTHY MALE KOREAN VOLUNTEERS: A SINGLE-DOSE, RANDOMIZED-SEQUENCE, OPEN-LABEL, TWO-WAY CROSSOVER STUDY.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 51. ISSUE 2. P. 152-160 | 6 | 86% | 1 |
3 | BANDERALI, G , RIVA, E , FIOCCHI, A , CORDARO, CI , GIOVANNINI, M , (1995) EFFICACY AND TOLERABILITY OF LEVODROPROPIZINE AND DROPROPIZINE IN CHILDREN WITH NONPRODUCTIVE COUGH.JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. VOL. 23. ISSUE 3. P. 175-183 | 8 | 89% | 18 |
4 | WESHAHY, SA , YAAQOB, MS , MORCOS, MN , HASSAN, DW , YOUSSEF, NF , (2015) SIMULTANEOUS DETERMINATION OF LEVODROPROPIZINE, METHYLPARABEN, AND PROPYLPARABEN IN ORAL CO-FORMULATED SYRUP BY RP-HPLC METHOD.JOURNAL OF THE CHILEAN CHEMICAL SOCIETY. VOL. 60. ISSUE 4. P. 2729 -2733 | 4 | 100% | 0 |
5 | GATTI, G , BARZAGHI, N , DOMINIJANNI, R , CORDARO, C , PERUCCA, E , (1993) ENANTIOSELECTIVE EFFECTS OF LEVODROPROPIZINE AND DROPROPIZINE ON PSYCHOMOTOR FUNCTIONS IN NORMAL VOLUNTEERS - A PLACEBO-CONTROLLED, DOUBLE-BLIND COMPARATIVE-STUDY.DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH. VOL. 19. ISSUE 1. P. 33-39 | 8 | 89% | 3 |
6 | HABEK, M , SUPE, S , POLJAKOVIC, Z , GELPI, E , ALESCH, F , OZRETIC, D , BRINAR, VV , (2008) SUBACUTE BRAINSTEM ANGIOENCEPHALOPATHY: FAVORABLE OUTCOME WITH ANTICOAGULATION THERAPY.JOURNAL OF THE NEUROLOGICAL SCIENCES. VOL. 275. ISSUE 1-2. P. 167-169 | 4 | 100% | 1 |
7 | ZANASI, A , LANATA, L , DE DANIELI, G , DICPINIGAITIS, PV , DE BLASIO, F , (2012) EFFICACY OF LEVODROPROPIZINE IN PEDIATRIC COUGH.PULMONARY PHARMACOLOGY & THERAPEUTICS. VOL. 25. ISSUE 5. P. 337-342 | 8 | 44% | 1 |
8 | PARK, KH , YUN, IS , CHOI, SY , LEE, JH , HONG, CS , PARK, JW , (2013) A CASE OF IMMUNOGLOBULIN E MEDIATED ANAPHYLAXIS TO LEVODROPROPIZINE.YONSEI MEDICAL JOURNAL. VOL. 54. ISSUE 1. P. 262-264 | 4 | 80% | 0 |
9 | FOUSSARDBLANPIN, O , MOREAU, S , NSABIYUMVA, F , (1996) CONSIDERATIONS ON AGE-ASSOCIATED MEMORY IMPAIRMENT..SEMAINE DES HOPITAUX. VOL. 72. ISSUE 21-22. P. 686-698 | 7 | 64% | 0 |
10 | FUMAGALLI, G , CORDARO, CI , VANASIA, M , BALZAROTTI, C , CAMUSSO, L , CAIAZZO, G , MAGHINI, L , MAZZOCCHI, M , ZENNARO, M , (1992) A COMPARATIVE-STUDY OF THE ANTITUSSIVE ACTIVITY OF LEVODROPROPIZINE AND DROPROPIZINE IN THE CITRIC ACID-INDUCED COUGH MODEL IN NORMAL SUBJECTS.DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH. VOL. 18. ISSUE 7. P. 303-309 | 6 | 86% | 6 |
Classes with closest relation at Level 1 |